Therapeutic indications:

Multiple Myeloma
Talizer Thalidomide + Wiserdex Dexamethasone is indicates as a first line therapy of patients recently diagnosed with multiple myeloma.
Recommended use by American Society of Hematologist (ASH)
Approved use by FDA 2005
New hope for the future of multiple myeloma as a malignant disease.
Indicated as maintenance therapy, recently diagnosed treatment, prevention of recurrence.

Leprosy Reaction
Talizer Thalidomide is the treatment of election in the reaction type II of leprosy known as (erythema nodosum leprosum) ENL
The association with neuritis in 56.4% of moderate and severe cases of ENL required the co-intervention with steroids.
Approved by WHO in 1967
Approved by FDA in 1998